Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

May
19
2017

The Symptoms of Basal Cell Carcinoma

The symptoms of basal cell carcinoma occasionally resemble the features of non-cancerous skin conditions like psoriasis or eczema. Only a trained physician or specialist can decide for sure if it is basal cell carcinoma. If…

May
12
2017

The Doctor’s Ultimate Wish List for Ending the Skin Cancer Epidemic

Despite tireless public awareness campaigns aimed at encouraging sun-safe behaviors and advances in skin cancer detection, the rates of this all-too-common, but highly preventable cancer continue to rise. Nearly 9,500 Americans are diagnosed with skin…

May
04
2017

Sensus Healthcare First Quarter Financial Results Feature Revenues up 43%

Sixth consecutive quarter of double-digit year-over-year revenue growth Conference call begins at 4:30 Eastern time today BOCA RATON, Fla., May 4, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the…

April
27
2017

Sensus Healthcare to Host First Quarter 2017 Financial Results and Business Update Conference Call on May 4, 2017

BOCA RATON, Fla., April 27, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announced today that…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy